|Awarded On||August 16, 2017|
|Title||Taking Texas Tobacco Free: Increasing Tobacco Cessation In Substance Use Treatment Centers via an Evidence-based, Comprehensive Tobacco-free Workplace Program|
|Award Mechanism||Tobacco Control and Lung Cancer Screening|
|Institution/Organization||University of Houston|
|Principal Investigator/Program Director||Lorraine Reitzel|
|Cancer Sites||Bladder, Cervix Uteri, Colorectal, Esophagus, Gallbladder, Head and Neck, Kidney and Renal Pelvis, Leukemia, Liver and Intrahepatic Bile Duct, Lung and Bronchus, Pancreas, Stomach|
Smoking, the most common form of tobacco use, is the leading preventable cause of death and disability in the US. Smoking causes 17 different types of cancers and is responsible for 30% of cancer deaths.
In recent decades, population-level tobacco control (TC) initiatives have been successful at reducing smoking rates overall; however, equivalent reductions are not being experienced among all population subgroups. One priority group in this regard is those with (non-nicotine) substance use disorders (SUDs), who are estimated to smoke at rates as high as 87%. Consequently, cancer incidence is also elevated in this group. Evidence-based practices (EBPs) known to be efficacious in reducin...